CAXTON CORP
CIK
1388551
Location
Princeton, NJ
Portfolio Value
Micro
$4,024,567
Diversification
Highly concentrated
Filing Date
Global Rank
#8,021
/ 8,232
▲ 199
Top Industry
Biotechnology
53.2%
3Y Alpha vs SPY
+9.0%
Period ended 2 months ago
Filed May 14, 2026 · 31d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+118.7%
SPY
+76.3%
Annualised alpha
+9.0%
Max drawdown
−72.9%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
7 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
81.5%
+13.7 pts
Top 5
97.8%
+5.8 pts
Top 10
100.0%
0.0 pts
HHI
6,743
Highly concentrated+1,963
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Unclassified | 81.5% | $3,280,100 |
| Healthcare | 9.8% | $396,089 |
| Financial Services | 8.7% | $348,378 |
Last Quarter's Activity
Export CSVTrimmed
Positions the filer reducedNo qualifying positions this quarter.
New Positions
Positions the filer opened this quarter
1 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ALXO | Alx Oncology Holdings Inc | 20,946 | $41,996 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
4 positions
7 positions ·
$4,024,567 total
· as of Mar 31, 2026
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| GLD |
Spdr Gold Trust
|
Added | 7,623 | $3,280,100 | 81.50% | |
| BRK-B |
Berkshire Hathaway Inc
Financial Services
|
Added | 727 | $348,378 | 8.66% | |
| KYTX |
Kyverna Therapeutics, Inc.
Healthcare
|
Held | 18,773 | $162,010 | 4.03% | |
| LXEO |
Lexeo Therapeutics, Inc.
Healthcare
|
Held | 13,943 | $80,032 | 1.99% | |
| XFOR |
X4 Pharmaceuticals, Inc
Healthcare
|
Held | 15,557 | $64,250 | 1.60% | |
| IKT |
Inhibikase Therapeutics, Inc.
Healthcare
|
Held | 28,453 | $47,801 | 1.19% | |
| ALXO |
Alx Oncology Holdings Inc
Healthcare
|
NEW | 20,946 | $41,996 | 1.04% |